Client Result
Orrick berät US-Software-Investor Turn/River Capital bei strategischer Investition in die Paessler AG
2 minute read | May.28.2024

2 minute read | May.28.2024
2 minute read | February.14.2024
Turn/River Capital has sold CoSoSys to Netwrix Corporation, a cybersecurity vendor focused on data security. Orrick represented Turn/River Capital.
2 minute read | November.15.2023
Vertu Capital, a private equity firm, has acquired ActiveState Software, a portfolio company of Turn/River Capital.
1 minute read | September.08.2023
2 minute read | February.03.2023
We advised Turn/River Capital on the acquisition by one of its portfolio companies, Redwood Software Inc., of Cerberus, LLC.
1 minute read | January.11.2023
June.27.2022
The primary focus of the acquisition is on the lead medicine, Tazverik® (tazemetostat), a first-in-class, chemotherapy-free EZH2a inhibitor.
January.25.2022
July.15.2021
January.08.2021
August.25.2020
April.24.2019